| __timestamp | Bristol-Myers Squibb Company | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 855506000 |
| Thursday, January 1, 2015 | 5920000000 | 996170000 |
| Friday, January 1, 2016 | 4940000000 | 1047690000 |
| Sunday, January 1, 2017 | 6411000000 | 1324625000 |
| Monday, January 1, 2018 | 6345000000 | 1416476000 |
| Tuesday, January 1, 2019 | 6148000000 | 1754540000 |
| Wednesday, January 1, 2020 | 11143000000 | 1829537000 |
| Friday, January 1, 2021 | 10195000000 | 3051100000 |
| Saturday, January 1, 2022 | 9509000000 | 2540300000 |
| Sunday, January 1, 2023 | 9299000000 | 3162900000 |
| Monday, January 1, 2024 | 11159000000 | 3630300000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Bristol-Myers Squibb consistently outspent Vertex Pharmaceuticals, with a peak in 2020 when their R&D expenses surged by nearly 125% compared to 2014. This strategic focus underscores their commitment to expanding their drug pipeline and maintaining a competitive edge. Meanwhile, Vertex Pharmaceuticals, while spending less in absolute terms, has shown a steady increase in R&D investment, growing by approximately 270% over the same period. This growth reflects their targeted approach to niche markets, particularly in genetic therapies.
These trends highlight the diverse strategies employed by pharmaceutical leaders to drive innovation and growth.
Eli Lilly and Company or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Analyzing R&D Budgets: Novartis AG vs Bristol-Myers Squibb Company
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
Vertex Pharmaceuticals Incorporated vs GSK plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Summit Therapeutics Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs CymaBay Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated or Dynavax Technologies Corporation: Who Invests More in Innovation?